Traitement médical de la lithiase urinaire [Medical treatment of urinary lithiasis].

Détails

ID Serval
serval:BIB_33231
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Traitement médical de la lithiase urinaire [Medical treatment of urinary lithiasis].
Périodique
Revue Médicale de la Suisse Romande
Auteur⸱e⸱s
Cachat F., Barbey F., Daudon M.
ISSN
0035-3655 (Print)
ISSN-L
0035-3655
Statut éditorial
Publié
Date de publication
2004
Volume
124
Numéro
8
Pages
461-464
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Urinary stone disease is frequent, and characterized by a high recurrence rate. Prevention of recurrent urolithiasis is possible using an appropriate diet with or without medications. Patients should be encouraged to have a high fluid intake. For an adult, urine volume should exceed 2000 ml/day. Diet modification should be done according to the various metabolic factors contributing to the formation of the stone (ie, hypercalciuria, hyperoxaluria, hypocitraturia, hyperuricuria, and so forth). Calcium intake should be around 1000 mg/day, protein intake limited to 1.2 g/kg/day, and salt intake kept to less than 100-150 mEq/jour. For uric acid urolithiasis, patient should limit uric acid intake to less than 500 mg/day. If these dietary manoeuvers fail, one can use thiazide diuretics to treat hypercalciuria, potassium citrate to correct hypocitraturia or sodium bicarbonate to alkalanize urine and prevent uric acid stone formation.
Mots-clé
Decision Trees, Humans, Urinary Calculi/therapy
Pubmed
Création de la notice
19/11/2007 13:32
Dernière modification de la notice
20/08/2019 14:18
Données d'usage